CTO of API Nanotronics to Speak At TAPPI June Conference

TAPPI and Alberta Ingenuity Fund are co-sponsoring the 2009 International Conference on Nanotechnology for the Forest Products Industry, scheduled for June 23-26, 2009 in Edmonton, Alberta Canada. The theme of this year's event is "Unlocking the Potential of Nano-Enabled Biomaterials."

Dr. Martin Moskovits will make a keynote presentation, "Nanooptics: Illuminating Nanostructures," on Friday, June 26. He is Chief Technology Officer of API Nanotronics Corp. (OTCBB:APIA) and President of API's NanoOpto division. The company is dedicated to designing and manufacturing optical components and optical sensors based on proprietary nanostructures and nanofabrication technologies.

From 2000 to 2007 Dr. Moskovits was Susan and Bruce Worster Dean of Science at the University of California Santa Barbara, where he participated in the establishment of the California Nanosystems Institute and the Institute for Collaborative Biotechnologies.

In 1965 he co-founded OHM Distributors and Manufacturers Ltd., an electronics manufacturing company which was sold in 1968. He has degrees in Physics and Chemistry from the University of Toronto. He received his PhD in 1971 in Physical Chemistry and was employed as a materials scientist by Alcan International, Kingston, Ont. He returned to the University of Toronto in 1973, eventually attaining the rank of Professor of Chemistry in 1982. From 1993-1999 he was Chair of the Department of Chemistry at University of Toronto.

He is a Fellow of the American Association for the Advancement of Science, the Optical Society of America and the Royal Society of Canada. He is the author or co-author of over 260 technical papers and listed as inventor on 18 patents.

Dr. Moskovits' presentation is part of a technical program including more than 40 presentations. Also conference delegates will tour Canada's National Institute for Nanotechnology (NINT) on Tuesday, June 23. Located on the University of Alberta campus in Edmonton, this 20,000 m2 research facility was founded in 2001. NINT is an integrated, multi-disciplinary institution with researchers in physics, chemistry, engineering, biology, informatics, pharmacy and medicine. Its objective is to discover design rules for nanotechnology and develop platforms for building nanosystems and materials that are constructed for specific applications. Delegates will hear brief presentations from NINT scientists and enjoy a reception with light refreshments.

This internationally known event brings together leading researchers, industry experts, government representatives and other stakeholders to share advances, perspectives and discuss new ideas and breakthrough concepts on nanotechnology-based advances. More details are available at www.tappi.org/09nano

Registration information is available through TAPPI's Member Connection Center, 1-800-332-8686 (US), 1-800-446-9431 (Canada), +1-770-446-1400, [email protected].

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Spectrum Control. (2019, February 14). CTO of API Nanotronics to Speak At TAPPI June Conference. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=10692.

  • MLA

    Spectrum Control. "CTO of API Nanotronics to Speak At TAPPI June Conference". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=10692>.

  • Chicago

    Spectrum Control. "CTO of API Nanotronics to Speak At TAPPI June Conference". AZoNano. https://www.azonano.com/news.aspx?newsID=10692. (accessed November 21, 2024).

  • Harvard

    Spectrum Control. 2019. CTO of API Nanotronics to Speak At TAPPI June Conference. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=10692.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.